[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution].
The bacterial strains isolated from patients diagnosed as having urinary tract infections (UTIs) in 10 institutions in Japan were supplied between the period of August 2000 and July 2001. Then, the susceptibilities of them to many kinds of antimicrobial agents were investigated. The number of them were 511 strains. The breakdown of these strains was Gram-positive bacteria as 29.0% and Gram-negative bacteria as 71.0%. Susceptibilities of these bacteria to antimicrobial agents were as follows; vancomycin (VCM), ampicillin (ABPC) and imipenem (IPM) showed strong activities against Enterococcus faecalis. No increase in low-susceptible strains of E. faecalis observed against these antimicrobial agents. VCM showed a strong activity against MRSA preventing growth of all strains with 1 microgram/ml. In addition, the activity of arbekacin (ABK) was strong with the MIC90 of 2 micrograms/ml against MRSA and prevented growth of all strains with 4 micrograms/ml. ABK showed a strong activity against Staphylococcus epidermidis preventing growth of all strains with 0.5 microgram/ml. ABPC, cefotiam (CTM) and cefozopran (CZOP) also showed a relatively strong activity against S. epidermidis (MIC90: 4 to 8 micrograms/ml). Against Escherichia coli, carbapenems showed high activities: meropenem (MEPM) prevented growth of all strains within 0.125 microgram/ml; IPM prevented growth of all strains with 0.25 microgram/ml. CZOP and CTM also showed strong activities against E. coli: MIC90 of CZOP was within 0.125 microgram/ml; MIC80 and MIC90 of CTM were 0.25 and 0.5 microgram/ml, respectively. Quinolone resistant E. coli was detected at frequency of 14.0%, which was significantly higher than that in the last year. Almost all drugs showed strong activities against Klebsiella pneumoniae and Proteus mirabilis, and MEPM prevented growth of all strains within 0.125 microgram/ml. Against Pseudomonas aeruginosa, almost drugs were not so active. The MIC90 of carbapenems and gentamicin (GM) were 16 micrograms/ml and those of all other drugs were more than 32 micrograms/ml. Against Serratia marcescens, the MIC90 of IPM and GM were the lowest value being 2 micrograms/ml, and that of MEPM was 4 micrograms/ml.
Kumamoto
Yoshiaki
Y
Department of Urology, Sapporo Medical University, School of Medicine.
Tsukamoto
Taiji
T
Fujime
Makoto
M
Fujita
Kazuhiko
K
Hirose
Takaoki
T
Matsukawa
Masanori
M
Takahashi
Satoshi
S
Kunishima
Yasuharu
Y
Igari
Jun
J
Ogihara
Masahiko
M
Ishibashi
Kei
K
Oguri
Toyoko
T
Shigeta
Shiro
S
Yamaguchi
Keizo
K
Matsumoto
Tetsuya
T
Kashitani
Fusako
F
Yoshida
Hiroshi
H
Imafuku
Yuuji
Y
Murai
Masaru
M
Ooe
Hiroshi
H
Nishikawa
Mineko
M
Watanabe
Kiyoaki
K
Kobayashi
Yoshio
Y
Uchida
Hiroshi
H
Oka
Toshitsugu
T
Kitamura
Masaya
M
Takano
Yuuji
Y
Matsuoka
Yasuhiro
Y
Matsuda
Seiji
S
Sato
Shinichi
S
Furuhama
Toshinari
T
Kumon
Hiromi
H
Monden
Koichi
K
Aoki
Siho
S
Mochida
Chikako
C
Hirakata
Yoichi
Y
Kohno
Shigeru
S
Miyazaki
Yoshitsugu
Y
Tomono
Kazunori
K
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000494:pharmacology*; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology*; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D014552:Urinary Tract Infections / Q000382:microbiology*
D042462:4-Quinolones; D000890:Anti-Infective Agents; D000892:Anti-Infective Agents, Urinary